Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion type Assertion NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_head.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion description "[Although the WT1 promoter region was significantly hypermethylated, two CpG sites located in Sp1 motifs were unmethylated in the majority of cases (68-74% of carcinomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_provenance.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion evidence source_evidence_literature NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_provenance.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion SIO_000772 9365158 NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_provenance.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion wasDerivedFrom befree-20140225 NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_provenance.
- NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_assertion wasGeneratedBy ECO_0000203 NP870307.RAzs2_T09ETGx-TsMFU-DzUb-mwOWykPPv7_AKV1iqWX4130_provenance.